Delivery Order SPE2DB22D3501-SPE2DB24FWE48
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,319.40 firm fixed-price contract is for the delivery of Entecavir 0.5 mg tablets, with a completion date of December 21, 2023. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,764.06 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg Tablets, with a period of performance through November 1, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a $3,067.66 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Entecavir 0.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Entecavir 0.5mg tablets. The contract, valued at $7,808.22, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
This federal contract award, valued at $10,186.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets in 30-count packages. This delivery order contract has an ultimate completion date of August 27, 2024 and is a firm fixed-price arrangement. No set-aside designation was used for this award. Amerisourcebergen is a significant supplier of pharmaceutical products and...
This federal contract award, valued at $11,317.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order, with a firm fixed price, to provide Entecavir 0.5 mg tablets. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,630.72 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets. The contract has an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.09 firm fixed-price delivery order contract is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has a completion date of June 14, 2023 and was awarded on June 13, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award for $1,361.61 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,015.95 Firm Fixed Price Delivery Order is for the supply of Entecavir 0.5 mg Tablet 30s, a medication used to treat hepatitis B. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. There was no set-aside designation for this open competition contract. Amerisourcebergen...